Role of mast cells in zymosan-induced peritoneal inflammation in Balb/c and mast cell-deficient WBB6F1 mice.
Zymosan-induced peritonitis was investigated in mast cell-deficient WBB6F1 mice and in Balb/c mice pretreated with mast cell stabilizer (cromolyn) or antagonists of histamine receptors (mepyramine, triprolidine, cimetidine, or ranitidine). The inherited mast cell deficiency in W/Wv knockouts of WBB6F1 mice impaired significantly the level of histamine and plasma exudation (measured 30 min after stimulation) as well as the influx of exudatory leukocytes, accumulation of plasma and exudate chemoattractants, and the release of proinflammatory cytokines (TNF-alpha, IL-1beta, and IL-6) measured at 6 h of inflammation. All of those factors were fully restored after selective intraperitoneal reconstitution of W/Wv mice with bone marrow-derived mast cells from their control +/+ counterparts. Cromolyn pretreatment of Balb/c mice reduced exclusively the early plasma exudation and histamine influx. Blocking of histamine receptors inhibited not only the early plasma exudation but also temporarily diminished primary leukocyte influx and levels of MCP-1 and IL-1beta. In conclusion, mast cells play an important role in the initiation of zymosan-induced peritonitis and modulate its further course.
Kolaczkowska
E
E
Department of Experimental Pathology, Institute of Medical Biology, University of Tromsø, Norway.
Seljelid
R
R
Plytycz
B
B
D000818:Animals; D018927:Anti-Asthmatic Agents / Q000494:pharmacology; D002927:Cimetidine / Q000494:pharmacology; D004205:Cromolyn Sodium / Q000494:pharmacology; D006633:Histamine Antagonists / Q000494:pharmacology; D007004:Hypoglycemic Agents / Q000633:toxicity; D008407:Mast Cells / Q000502:physiology*; D051379:Mice; D008807:Mice, Inbred BALB C; D018345:Mice, Knockout; D010538:Peritonitis / Q000139:chemically induced / Q000378:metabolism / Q000503:physiopathology*; D011738:Pyrilamine / Q000494:pharmacology; D011899:Ranitidine / Q000494:pharmacology; D011968:Receptors, Histamine / Q000502:physiology; D014311:Triprolidine / Q000494:pharmacology; D015054:Zymosan / Q000633:toxicity
D018927:Anti-Asthmatic Agents; D006633:Histamine Antagonists; D007004:Hypoglycemic Agents; D011968:Receptors, Histamine; D014311:Triprolidine; D002927:Cimetidine; D011899:Ranitidine; D015054:Zymosan; D011738:Pyrilamine; D004205:Cromolyn Sodium